TY - JOUR
T1 - αDefensins induce a post-translational modification of low density lipoprotein (LDL) that promotes atherosclerosis at normal levels of plasma cholesterol
AU - Abu-Fanne, Rami
AU - Maraga, Emad
AU - Abd-Elrahman, Ihab
AU - Hankin, Aviel
AU - Blum, Galia
AU - Abdeen, Suhair
AU - Hijazi, Nuha
AU - Cines, Douglas B.
AU - Higazi, Abd Al Roof
N1 - Publisher Copyright:
©2016 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2016/2/5
Y1 - 2016/2/5
N2 - Approximately one-half of the patients who develop clinical atherosclerosis have normal or only modest elevations in plasma lipids, indicating that additional mechanisms contribute to pathogenesis. In view of increasing evidence that inflammation contributes to atherogenesis, we studied the effect of human neutrophil α-defensins on low density lipoprotein (LDL) trafficking, metabolism, vascular deposition, and atherogenesis using transgenic mice expressing human α-defensins in their polymorphonuclear leukocytes (Def+/+). Accelerated Def+/+ mice developed α-defensin·LDL complexes that accelerate the clearance of LDL from the circulation accompanied by enhanced vascular deposition and retention of LDL, induction of endothelial cathepsins, increased endothelial permeability to LDL, and the development of lipid streaks in the aortic roots when fed a regular diet and at normal plasma levels of LDL. Transplantation of bone marrow from Def+/+ to WT mice increased LDL clearance, increased vascular permeability, and increased vascular deposition of LDL, whereas transplantation ofWTbone marrow to Def+/+ mice prevented these outcomes. The same outcome was obtained by treating Def+/+ mice with colchicine to inhibit the release of α-defensins. These studies identify a potential new link between inflammation and the development of atherosclerosis.
AB - Approximately one-half of the patients who develop clinical atherosclerosis have normal or only modest elevations in plasma lipids, indicating that additional mechanisms contribute to pathogenesis. In view of increasing evidence that inflammation contributes to atherogenesis, we studied the effect of human neutrophil α-defensins on low density lipoprotein (LDL) trafficking, metabolism, vascular deposition, and atherogenesis using transgenic mice expressing human α-defensins in their polymorphonuclear leukocytes (Def+/+). Accelerated Def+/+ mice developed α-defensin·LDL complexes that accelerate the clearance of LDL from the circulation accompanied by enhanced vascular deposition and retention of LDL, induction of endothelial cathepsins, increased endothelial permeability to LDL, and the development of lipid streaks in the aortic roots when fed a regular diet and at normal plasma levels of LDL. Transplantation of bone marrow from Def+/+ to WT mice increased LDL clearance, increased vascular permeability, and increased vascular deposition of LDL, whereas transplantation ofWTbone marrow to Def+/+ mice prevented these outcomes. The same outcome was obtained by treating Def+/+ mice with colchicine to inhibit the release of α-defensins. These studies identify a potential new link between inflammation and the development of atherosclerosis.
UR - http://www.scopus.com/inward/record.url?scp=84958214666&partnerID=8YFLogxK
U2 - 10.1074/jbc.M115.669812
DO - 10.1074/jbc.M115.669812
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26518877
AN - SCOPUS:84958214666
SN - 0021-9258
VL - 291
SP - 2777
EP - 2786
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 6
ER -